Table 3.
Site | Model | Weighta | Diversity | AE | RE | ReRMSE | Improvement (MM > SM) |
---|---|---|---|---|---|---|---|
Baseline performance | |||||||
Malindi | EPIFIL | 0.60 | 2.34 | 3.98 | 0.16 | 0.45 | −0.07 |
LYMFASIM | 0.29 | 7.46 | 5.58 | 0.22 | 0.60 | 0.21 | |
TRANSFIL | 0.11 | 7.03 | 8.97 | 0.36 | 1.43 | 0.67 | |
MM Ensemble | – | 3.08 | 4.15 | 0.17 | 0.48 | – | |
Nanaha | EPIFIL | 0.32 | 5.25 | 11.69 | 0.19 | 0.81 | −0.28 |
LYMFASIM | 0.41 | 10.10 | 9.71 | 0.16 | 0.90 | −0.15 | |
TRANSFIL | 0.27 | 8.23 | 11.70 | 0.19 | 1.43 | 0.28 | |
MM Ensemble | – | 8.91 | 10.83 | 0.18 | 1.04 | – | |
Pondicherry | EPIFIL | 0.17 | 1.14 | 2.26 | 0.27 | 0.88 | 0.22 |
LYMFASIM | 0.75 | 1.86 | 1.20 | 0.14 | 0.56 | −0.23 | |
TRANSFIL | 0.08 | 5.14 | 3.61 | 0.43 | 0.91 | 0.25 | |
MM Ensemble | – | 2.41 | 1.61 | 0.19 | 0.68 | – | |
Post-intervention performance | |||||||
Malindi | EPIFIL | – | 0.50 | 3.78 | 0.41 | 0.90 | 0.01 |
LYMFASIM | – | 2.47 | 4.81 | 0.52 | 0.83 | −0.07 | |
TRANSFIL | – | 3.93 | 3.25 | 0.35 | 0.71 | −0.26 | |
MM Ensemble | – | 2.10 | 3.87 | 0.42 | 0.89 | – | |
Nanaha | EPIFIL | – | 1.83 | 8.93 | 0.49 | 1.33 | 0.20 |
LYMFASIM | – | 7.01 | 23.23 | 1.28 | 1.10 | 0.03 | |
TRANSFIL | – | 8.53 | 8.04 | 0.44 | 0.72 | −0.48 | |
MM Ensemble | – | 13.64 | 12.24 | 0.68 | 1.07 | – | |
Pondicherry | EPIFIL | – | 1.56 | 2.93 | 0.53 | 1.13 | 0.18 |
LYMFASIM | – | 0.96 | 0.70 | 0.13 | 0.90 | −0.02 | |
TRANSFIL | – | 2.70 | 1.97 | 0.36 | 0.95 | 0.03 | |
MM Ensemble | – | 1.89 | 1.66 | 0.30 | 0.93 | – |
Weights derived during calibration are used in validation.